New Devices in Glaucoma

Lilian Chan; Marlene R. Moster; Amanda K. Bicket; Arsham Sheybani; Steven R. Sarkisian; Thomas W. Samuelson; Iqbal Ike K. Ahmed; Eydie Miller-Ellis; Oluwatosin U. Smith; Qi N. Cui

doi:10.1007/s40123-023-00780-3

New Devices in Glaucoma

Lilian Chan, Marlene R. Moster, Amanda K. Bicket, Arsham Sheybani, Steven R. Sarkisian, Thomas W. Samuelson, Iqbal Ike K. Ahmed, Eydie Miller-Ellis, Oluwatosin U. Smith, Qi N. Cui

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.

Original language	English
Pages (from-to)	2381-2395
Number of pages	15
Journal	Ophthalmology and Therapy
Volume	12
Issue number	5
DOIs	https://doi.org/10.1007/s40123-023-00780-3
State	Published - Oct 2023

Keywords

Delayed-action preparation
Excimer laser trabeculostomy
Glaucoma
Glaucoma drainage implants
MINIject
Minimally invasive glaucoma surgery
Minimally invasive micro sclerostomy
Multi-pressure dial
Visiplate
iDOSE

Access to Document

10.1007/s40123-023-00780-3

Cite this

@article{ff4b2012c6a44ac8af649b81153df46d,

title = "New Devices in Glaucoma",

abstract = "Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm{\textquoteright}s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.",

keywords = "Delayed-action preparation, Excimer laser trabeculostomy, Glaucoma, Glaucoma drainage implants, MINIject, Minimally invasive glaucoma surgery, Minimally invasive micro sclerostomy, Multi-pressure dial, Visiplate, iDOSE",

author = "Lilian Chan and Moster, {Marlene R.} and Bicket, {Amanda K.} and Arsham Sheybani and Sarkisian, {Steven R.} and Samuelson, {Thomas W.} and Ahmed, {Iqbal Ike K.} and Eydie Miller-Ellis and Smith, {Oluwatosin U.} and Cui, {Qi N.}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = oct,

doi = "10.1007/s40123-023-00780-3",

language = "English",

volume = "12",

pages = "2381--2395",

journal = "Ophthalmology and Therapy",

issn = "2193-8245",

number = "5",

}

TY - JOUR

T1 - New Devices in Glaucoma

AU - Chan, Lilian

AU - Moster, Marlene R.

AU - Bicket, Amanda K.

AU - Sheybani, Arsham

AU - Sarkisian, Steven R.

AU - Samuelson, Thomas W.

AU - Ahmed, Iqbal Ike K.

AU - Miller-Ellis, Eydie

AU - Smith, Oluwatosin U.

AU - Cui, Qi N.

PY - 2023/10

Y1 - 2023/10

N2 - Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.

AB - Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.

KW - Delayed-action preparation

KW - Excimer laser trabeculostomy

KW - Glaucoma

KW - Glaucoma drainage implants

KW - MINIject

KW - Minimally invasive glaucoma surgery

KW - Minimally invasive micro sclerostomy

KW - Multi-pressure dial

KW - Visiplate

KW - iDOSE

UR - http://www.scopus.com/inward/record.url?scp=85167355493&partnerID=8YFLogxK

U2 - 10.1007/s40123-023-00780-3

DO - 10.1007/s40123-023-00780-3

M3 - Review article

C2 - 37558818

AN - SCOPUS:85167355493

SN - 2193-8245

VL - 12

SP - 2381

EP - 2395

JO - Ophthalmology and Therapy

JF - Ophthalmology and Therapy

IS - 5

ER -

New Devices in Glaucoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this